News coverage about athenahealth (NASDAQ:ATHN) has been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group scores the sentiment of news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. athenahealth earned a daily sentiment score of 0.18 on Accern’s scale. Accern also assigned press coverage about the health services provider an impact score of 47.8932649134261 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Shares of athenahealth (NASDAQ:ATHN) traded down $1.93 during trading hours on Wednesday, hitting $144.08. 68,456 shares of the stock traded hands, compared to its average volume of 495,200. The stock has a market capitalization of $5,880.00, a P/E ratio of 118.19, a price-to-earnings-growth ratio of 2.58 and a beta of 1.17. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.32. athenahealth has a 1-year low of $95.01 and a 1-year high of $158.66.
athenahealth (NASDAQ:ATHN) last announced its quarterly earnings data on Thursday, February 1st. The health services provider reported $1.11 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.63 by $0.48. athenahealth had a net margin of 4.35% and a return on equity of 9.21%. The firm had revenue of $329.20 million during the quarter, compared to analysts’ expectations of $319.64 million. During the same quarter last year, the business earned $0.62 earnings per share. The business’s revenue for the quarter was up 14.2% compared to the same quarter last year. sell-side analysts forecast that athenahealth will post 2.69 earnings per share for the current fiscal year.
In other athenahealth news, Director Amy Abernethy sold 500 shares of athenahealth stock in a transaction dated Tuesday, December 26th. The shares were sold at an average price of $134.18, for a total transaction of $67,090.00. Following the completion of the transaction, the director now owns 4,045 shares in the company, valued at $542,758.10. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Jonathan Bush sold 250 shares of athenahealth stock in a transaction dated Thursday, March 1st. The stock was sold at an average price of $139.27, for a total transaction of $34,817.50. Following the sale, the chief executive officer now owns 321,533 shares of the company’s stock, valued at $44,779,900.91. The disclosure for this sale can be found here. Insiders sold 108,705 shares of company stock valued at $14,891,199 in the last quarter. Company insiders own 3.20% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This news story was originally posted by BBNS and is owned by of BBNS. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this news story can be viewed at https://baseballnewssource.com/2018/03/14/athenahealth-athn-receiving-somewhat-favorable-press-coverage-report-shows/1889911.html.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.